Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2023 Earnings Call Transcript
Operator: Good day and welcome to the Sensus Healthcare Fourth Quarter and Full Year 2023 Financial Results Conference Call. All participants will be in a listen-only mode.
Sensus Healthcare Inc. (SRTS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 176,750 | $417,130 | -5% | 0.02% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 88,500 | $208,860 | -16% | 0% |
| 3. | D E Shaw D. E. Shaw | 62,756 | $148,105 | -18% | 0% |
| 4. | Renaissance Technologies Jim Simons | 290,748 | $686,000 | -13% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.88 | 10,000 | 1,175,293 | 2023-09-14 | Filing | ||
| $2.99 | 1,000 | 58,774 | 2023-08-28 | Filing | ||
| $3.78 | 1,000 | 57,774 | 2023-08-08 | Filing | ||
| $3.86 | 10,000 | 1,165,293 | 2023-08-08 | Filing | ||
| $2.86 | 10,000 | 79,940 | 2023-05-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.13 | 5,000 | 49,519 | 2022-09-13 | Filing | ||
| $12.58 | 15,794 | Officer, Director | 1,130,293 | 2022-09-07 | Filing | |
| $12.56 | 15,794 | Officer, Director | 1,146,087 | 2022-09-06 | Filing | |
| $12.42 | 10,000 | Officer, Director | 1,161,881 | 2022-09-02 | Filing | |
| $14.21 | 28,999 | 1,171,881 | 2022-08-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 779,052 | $1,838,563 | 0% | |
| 2. | 131,280 | $309,820 | 0% | |
| 3. | 130,586 | $308,183 | 0.17% | |
| 4. | 127,617 | $301,247 | 0% | |
| 5. | 104,810 | $247,351 | 0.11% |
News See All
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Sensus Healthcare Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded.
5 Best Nano Cap Stocks To Buy Now
In this piece, we will take a look at the five best nano cap stocks to buy now.
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Sensus Healthcare First Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode.
12 Cheap Healthcare Stocks to Buy in 2023
The healthcare sector is one of the few industries that has rapidly transformed itself in just a couple of decades.
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2022 Earnings Call Transcript
Operator: Welcome to the Sensus Healthcare Fourth Quarter 2022 Earnings Conference Call. . Please also note that this event is being recorded today.
5 Best Medical Device Stocks To Buy Now
Founded in 1931, Baxter International Inc. (NYSE:BAX) is a medical equipment company. After acquiring Hillrom in late 2021, the company has added more to its hospital-based products.
10 Stocks That Recently Hit All-Time Highs
The predominant theme of the 2022 stock market is uncertainty, and Russia’s invasion of Ukraine has spun the stock market out of control as investors were already facing inflation and elevated interest...
Is Sensus Healthcare, Inc. (SRTS) A Good Stock To Buy?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Sensus Healthcare Inc (SRTS) Expanding Markets For Painless, Cost-Effective Skin Cancer Treatment
Sensus Healthcare Inc (NASDAQ:SRTS) is a medical device company that develops a unique, low-dose photon radio therapy, known as superficial radiation therapy (SRT), used to treat skin cancer and keloids...
Billionaire Hedge Funds
